Xenon Pharmaceuticals

Developer of small molecule drugs against rare channelopathies

placeBurnaby, British Columbia, Canada calendar_todayFounded 2000 groups19 employees language xenon-pharma.com

Registered entities

Social engagement

Social engagement: 27K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

16 investors on record; lead investors include Fidelity Investments, Invesco; 2 have since exited.

Investor typeCountShare
Venture capital956%
Bank & private debt16%
Other / undisclosed638%

Hiring activity

Hires periodically

15 roles tracked across 4 of the last 12 months

14 Feb 2026 · CMC Analytical Chemistry Lead for Next-Gen Neuro Drugs · Toronto

13 Feb 2026 · Associate Director, Quality Assurance, GMP · Burnaby

13 Feb 2026 · Associate Director, GMP QA — Lead Compliance & Inspections · Burnaby

21 Jan 2026 · Director/Senior Director, Bioanalytical · Toronto

21 Dec 2025 · Senior QA Director, GMP & Compliance · Burnaby

Based on job postings tracked across public sources.

Recent activity

29 Jun 2026
Recognition
17 Jun 2026
Leadership hire
Senior Medical Director, Clinical Development
15 Jun 2026
Recognition
Coming soon